Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014

2nd Annual Discovery Chemistry & Drug Design Congress 2014

02 Jun 2014 - 03 Jun 2014 - Geneva, Switzerland

Bookmark and Share

Oxford Global Conferences are pleased to announce the 2nd Annual Discovery Chemistry & Drug Design Congress, taking place at the Intercontinental Geneva on 2 & 3 June 2014. This two day congress has been developed to offer discovery chemistry leaders an executive platform for networking and discussion. Our expert speakers will discuss methods of improving solubility, drugability and potency, while combatting the challenges of an increased demand for molecular complexity. Delegates will hear case studies covering a range of topics, including fragment based discovery, computer aided design for biologics and the role of natural products in discovery chemistry. The congress is part of the 15th Annual Drug Discovery Summit – Europe’s premier networking and discussion forum for pharmaceutical leaders. The congress is also co-located with the 6th Annual Drug Development Congress, a two day event focused on predictive science and translational medicine. Contact Danielle Dalby for more information on attendance, prices or to download the agenda on

Further information
Scientific News
Drug Target for Triple-Negative Breast Cancer Found
A team of researchers led by UC San Francisco scientists has identified a new drug target for triple-negative breast cancer.
Smartphone Laboratory Detects Cancer
Researchers develop low-cost, portable laboratory on a smartphonecapable of analysing multiple samples simultaneously.
First Entirely 3D-printed Organ-on-a-Chip with Integrated Sensors
New approach to manufacturing may allow researchers to rapidly design organs-on-chips that match the properties of a specific disease or individual patient's cells.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Stiffening a Blow to Cancer Cells
Researchers develop a way to predict how a tumor tissue's physical properties affect its response to chemotherapy drugs.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos